Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195558 · ClinicalTrials.gov registry record
Patient Registry of Blind Subjects With Sleep-related Problems
A clinical trial of Sleep-wake Disorder in Blind Individuals, sponsored by Vanda Pharmaceuticals.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT01195558 is a study of Sleep-wake Disorder in Blind Individuals that is actively recruiting participants, run by Vanda Pharmaceuticals. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01195558, a study of Sleep-wake Disorder in Blind Individuals, is actively recruiting participants, sponsored by Vanda Pharmaceuticals.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-24-hour sleep-wake disorder (Non-24) is a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness. This is a research protocol to develop a patient registry of subjects who may suffer from Non-24 and who are blind. Subjects participate in the study through a phone survey. This registry will be used to better understand, sleep related problems in blind individuals, including the investigation of a potential treatment, recruitment for future clinical studies, and to provide a forum for raising awareness about Non-24. The survey consists of questions regarding the degree of vision impairment and sleep problems that the subjects may be experiencing.
Conditions Studied
Interventions
- OTHER Data collection on blindness and sleep problems
Study Locations (1)
District of Columbia
- Vanda Pharmaceuticals - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2010-04 |
| Est. Completion | 2030-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01195558
The ClinicalTrials.gov registry entry for NCT01195558 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanda Pharmaceuticals, which has 68 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep-wake Disorder in Blind Individuals appearing as the primary indexed condition, and to 1 intervention - of which Data collection on blindness and sleep problems is the first listed.
NCT01195558 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01195558 about?
NCT01195558 is a clinical study titled "Patient Registry of Blind Subjects With Sleep-related Problems". Non-24-hour sleep-wake disorder (Non-24) is a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness. This is a research protocol to develop a patient registry of subjects who may suffer from Non-24 and who are blind....
What is the current status of trial NCT01195558?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2010-04. Estimated completion is 2030-04.
What conditions does trial NCT01195558 study?
This clinical trial studies the following conditions: Sleep-wake Disorder in Blind Individuals.
What interventions are being tested in trial NCT01195558?
The interventions under investigation include: Data collection on blindness and sleep problems (OTHER).
Who is sponsoring clinical trial NCT01195558?
This trial is sponsored by Vanda Pharmaceuticals, which has 68 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01195558 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.